167 related articles for article (PubMed ID: 7064804)
1. Vasodilators in heart failure secondary to coronary artery disease.
Parmley WW; Rouleau JL; Chatterjee K
Am Heart J; 1982 Apr; 103(4 Pt 2):625-32. PubMed ID: 7064804
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure.
Chatterjee K; Rouleau JL
Acta Med Scand Suppl; 1981; 651():295-303. PubMed ID: 7034478
[TBL] [Abstract][Full Text] [Related]
3. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
[TBL] [Abstract][Full Text] [Related]
5. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
Magorien RD; Brown GP; Unverferth DV; Nelson S; Boudoulas H; Bambach D; Leier CV
Circulation; 1982 Mar; 65(3):528-33. PubMed ID: 7055874
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
Kodama K; Koretsune Y; Nanto S; Taniura K
Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
[TBL] [Abstract][Full Text] [Related]
7. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Mason DT
Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
[TBL] [Abstract][Full Text] [Related]
8. [Peripheral vasodilators in the treatment of heart failure].
Serbin VI; Gasanova AS
Pediatriia; 1982 Jan; (1):67-70. PubMed ID: 7038611
[No Abstract] [Full Text] [Related]
9. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
[TBL] [Abstract][Full Text] [Related]
10. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
Adigun AQ; Ajayi OE; Sofowora GG; Ajayi AA
Int J Cardiol; 1998 Nov; 67(1):81-6. PubMed ID: 9880204
[TBL] [Abstract][Full Text] [Related]
11. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
Shevchenko VA
Vrach Delo; 1983 Oct; (10):8-12. PubMed ID: 6139918
[No Abstract] [Full Text] [Related]
13. Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies.
Haq A; Rakowski H; Baigrie R; McLaughlin P; Burns R; Tihal H; Hilton D; Feiglin D
Am J Cardiol; 1982 Feb; 49(2):439-44. PubMed ID: 6800252
[TBL] [Abstract][Full Text] [Related]
14. The effect of nitroglycerin on pacing-induced changes in myocardial oxygen consumption and metabolic coronary vasodilation in patients with coronary artery disease.
Kal JE; Vergroesen I; van Wezel HB
Anesth Analg; 1999 Feb; 88(2):271-8. PubMed ID: 9972740
[TBL] [Abstract][Full Text] [Related]
15. Results of long-term vasodilator therapy in patients with refractory congestive heart failure.
Walsh WF; Greenberg BH
Circulation; 1981 Sep; 64(3):499-505. PubMed ID: 7261282
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
Massie BM; Kramer B; Shen E; Haughom F
Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
[TBL] [Abstract][Full Text] [Related]
17. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
Timmis AD; Richardson PJ
Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
[No Abstract] [Full Text] [Related]
18. Hemodynamic effects of vasodilators and long-term response in heart failure.
Franciosa JA; Dunkman WB; Leddy CL
J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
[TBL] [Abstract][Full Text] [Related]
19. Vasodilators in the treatment of congestive heart failure.
Ciafone RA
Conn Med; 1983 Oct; 47(10):614-8. PubMed ID: 6414758
[No Abstract] [Full Text] [Related]
20. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
Mantle JA; Russell RO; Moraski RE; Rackley CE
Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
